An Associated Press story looks at how the pharmaceutical industry managed not just its reputation, but its bottom line in the battle leading up to the passage of the health bill.
The AP cites the role that PhRMA played in developing and implementing the lobby strategy. Also this week, an industry group, called Americans for Stable Quality Care, launched an ad campaign in Washington, thanking Democrats who voted for the bill.
From the March 29 story:
"Pharma came out of this better than anyone else," said Ramsey Baghdadi, a Washington health policy analyst who projects a $30 billion, 10-year net gain for the industry. "I don't see how they could have done much better."
Billy Tauzin, president of PhRMA, said in February that he would step down from his position. No replacement was named.